Ronnie Givens, MD
Obstetrics & Gynecology · Summerville, SCNPI 1063486751
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 345 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 41 manufacturers reported payments, led by AbbVie at 24.1% of the total. Among obstetrics & gynecology clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 345 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sumitomo Pharma America, Inc.$1K
- Hologic Sales And Service, LLC$427
- Mayne Pharma Commercial LLC$296
- Exeltis, USA Inc.$255
- Shield Therapeutics Inc$238
- plus $3K from 35 others
Across 247 payments — averaging $2564.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$338K
- Merck$73K
- Organon$72K
- Bayer$71K
- Sumitomo Pharma America, Inc.$54K
- Myovant Sciences GmbH$13K
- plus $12K from 2 others
What the payments were for
- Food & beverage$6,389100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 104 | $1,541 |
| Sumitomo Pharma America, Inc. | 44 | $1,071 |
| Hologic Sales And Service, LLC | 17 | $427 |
| Mayne Pharma Commercial LLC | 14 | $296 |
| Exeltis, USA Inc. | 15 | $255 |
| Shield Therapeutics Inc | 12 | $238 |
| Myovant Sciences Inc. | 15 | $226 |
| Bayer | 11 | $175 |
| Millicent US Inc | 9 | $175 |
| Organon | 13 | $164 |
| Aspira Women's Health Inc | 3 | $164 |
| Optumhealth Care Solutions, LLC | 9 | $134 |
| Channel Medsystems, Inc. | 2 | $133 |
| Sage Therapeutics, LLC | 5 | $128 |
| Pfizer | 7 | $122 |
| Agile Therapeutics, Inc. | 7 | $117 |
| Therapeuticsmd, Inc. | 7 | $114 |
| Mylan Pharmaceuticals Inc. | 4 | $95 |
| Astellas Pharma US Inc | 5 | $93 |
| Scynexis, Inc. | 4 | $85 |
| Momentis Surgical Inc. | 1 | $74 |
| Avion Pharmaceuticals | 5 | $66 |
| Exact Sciences | 4 | $66 |
| Merck | 6 | $58 |
| Duchesnay USA Incorporated | 3 | $43 |
| Evofem Biosciences, Inc. | 3 | $38 |
| Coopersurgical, Inc. | 1 | $36 |
| Davol Inc. | 1 | $30 |
| Minerva Surgical, Inc | 2 | $28 |
| Novo Nordisk | 1 | $27 |
| Meditrina | 1 | $23 |
| Mycovia Pharmaceuticals, Inc. | 1 | $22 |
| Sanara Medtech Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Axonics, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Gynesonics, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Avanos Medical | 1 | $12 |
| Lupin Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,389 in reported general payments places this provider in the 90th percentile of 673 obstetrics & gynecology providers in South Carolina.
See all obstetrics & gynecology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 109 | $3,186 |
| Estradiol (Twice Weekly)Estradiol | 24 | $2,364 |
| Clobetasol Propionate | 13 | $376 |
| ValacyclovirValacyclovir Hcl | 13 | $203 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $132 |
| Metronidazole | 13 | $90 |
| Sertraline Hcl | 18 | $82 |
| Fluconazole | 16 | $77 |
| Alprazolam | 11 | $28 |
| Medroxyprogesterone Acetate | 14 | $7 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Summerville
- Martha CohenSummerville$10K
- Brittany StofkoSummerville$8K
- Jennifer HeinemannSummerville$7K
- Hunter SmithSummerville$6K
- Christine HunterSummerville$6K
- William ReevesSummerville$6K
- Beth CookSummerville$6K
- Christopher JenningsAnderson$1.3M
- William ColemanGreenville$242K
- Melvin SeidMauldin$235K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.